Pancreatic Cancer in Chronic Pancreatitis

Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andren-Sandberg A, Domellof L (1993) Pancreatitis and the risk of pancreatic cancer. International pancreatitis study group. N Engl J Med 328(20):1433–7

Ekbom A, McLaughlin JK, Nyren O (1993) Pancreatitis and the risk of pancreatic cancer. N Engl J Med 329(20):1502–3

Farrow B, Sugiyama Y, Chen A, Uffort E, Nealon W, Mark Evers B (2004) Inflammatory mechanisms contributing to pancreatic cancer development. Ann Surg 239(6):763–9, discussion 769-71

Balakrishnan V, Unnikrishnan AG, Thomas V, Choudhuri G, Veeraraju P, Singh SP, Garg P, Pai CG, Devi RN, Bhasin D, Jayanthi V, Premalatha N, Chacko A, Kar P, Rai RR, Rajan R, Subhalal N, Mehta R, Mishra SP, Dwivedi M, Vinayakumar KR, Jain AK, Biswas K, Mathai S, Varghese J, Ramesh H, Alexander T, Philip J, Raj VV, Vinodkumar A, Mukevar S, Sawant P, Nair P, Kumar H, Sudhindran S, Dhar P, Sudheer OV, Sundaram KR, Tantri BV, Singh D, Nath TR (2008) Chronic pancreatitis. A prospective nationwide study of 1,086 subjects from India. JOP 9(5):593–600

Mori M, Hariharan M, Anandakumar M, Tsutsumi M, Ishikawa O, Konishi Y et al (1999) A case control study on the risk factors for pancreatic diseases in Kerala, India. Hepatogastroenterology 46:25–3

Chari ST, Mohan V, Pitchumoni CS, Viswanathan M, Madanagopalan N, Lowenfels AB (1994) Risk of pancreatic carcinoma in tropical calcifying pancreatitis: an epidemiologic study. Pancreas 9(1):62–6

Karlson BM, Ekbom A, Josefsson S, McLaughlin JK, Fraumeni JF Jr, Nyren O (1997) The risk of pancreatic cancer following pancreatitis: an association due to confounding? Gastroenterology 113(2):587–92

Ekbom A, McLaughlin JK, Karlsson BM, Nyren O, Gridley G, Adami HO, Fraumeni JF Jr (1994) Pancreatitis and pancreatic cancer: a population-based study. J Natl Cancer Inst 86(8):625–7

Balakrishnan V, Nair P, Radhakrishnan L, Narayanan VA (2006) Tropical pancreatitis - a distinct entity, or merely a type of chronic pancreatitis? Indian J Gastroenterol 25(2):74–81

Augustine P, Ramesh H (1992) Is tropical pancreatitis premalignant? Am J Gastroenterol 87(8):1005–8

Yadav D, Lowenfels AB (2013) The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 144(6):1252–61

Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, Truninger K, Ammann R, Cavallini G, Charnley RM, Uomo G, Delhaye M, Spicak J, Drumm B, Jansen J, Mountford R, Whitcomb DC, Neoptolemos JP, European Registry of Hereditary, and C. Pancreatic (2004) Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2(3):252–61

Duell EJ, Lucenteforte E, Olson SH, Bracci PM, Li D, Risch HA, Silverman DT, Ji BT, Gallinger S, Holly EA, Fontham EH, Maisonneuve P, Bueno-de-Mesquita HB, Ghadirian P, Kurtz RC, Ludwig E, Yu H, Lowenfels AB, Seminara D, Petersen GM, La Vecchia C, Boffetta P (2012) Pancreatitis and pancreatic cancer risk: a pooled analysis in the international pancreatic cancer case-control consortium (PanC4). Ann Oncol 23(11):2964–70

Whitcomb D, Greer J (2009) Germ-line mutations, pancreatic inflammation, and pancreatic cancer. Clin Gastroenterol Hepatol 7(11 Suppl):S29–34

Greer JB, Whitcomb DC (2009) Inflammation and pancreatic cancer: an evidence-based review. Curr Opin Pharmacol 9(4):411–8

Kolodecik T, Shugrue C, Ashat M, Thrower EC (2013) Risk factors for pancreatic cancer: underlying mechanisms and potential targets. Front Physiol 4:415

Li D (2012) Diabetes and pancreatic cancer. Mol Carcinog 51(1):64–74

Stolzenberg-Solomon RZ, Graubard BI, Chari S, Limburg P, Taylor PR, Virtamo J, Albanes D (2005) Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 294(22):2872–8

Fisher WE (2001) Diabetes: risk factor for the development of pancreatic cancer or manifestation of the disease? World J Surg 25(4):503–8

Liao KF, Lai SW, Li CI, Chen WC (2012) Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan. J Gastroenterol Hepatol 27(4):709–13

Tod J, Jenei V, Thomas G, Fine D (2013) Tumor-stromal interactions in pancreatic cancer. Pancreatology 13(1):1–7

Andersen DK, Andren-Sandberg A, Duell EJ, Goggins M, Korc M, Petersen GM, Smith JP, Whitcomb DC (2013) Pancreatitis-diabetes-pancreatic cancer. Summary of an NIDDK-NCI workshop. Pancreas 42:1227–37

Gold EB, Cameron JL (1993) Chronic pancreatitis and pancreatic cancer. N Engl J Med 328(20):1485–6

Fernandez E, La Vecchia C, Porta M, Negri E, d’Avanzo B, Boyle P (1995) Pancreatitis and the risk of pancreatic cancer. Pancreas 11(2):185–9

Chakraborty PP, Dutta D, Biswas K, Sanyal T, Ghosh S, Mukhopadhyay S, Chowdhury S (2012) Pancreatic carcinoma in fibrocalcific pancreatic diabetes: an eastern India perspective. Indian J Endocrinol Metab 16:S486–8

Sudhindran S, Krishnan P (2006) Early detection of malignancy in tropical pancreatitis – is it possible? In: Balakrishnan V (ed) Chronic pancreatitis and pancreatic diabetes in India. L.G. Creations, Bangalore, pp 364–70

Hariharan M, Subhalal N, Anandakumar M, Chellam VG, Iype S (2006) Chronic calcific pancreatitis of the tropics with carcinoma. In: Balakrishnan V (ed) Chronic pancreatitis and pancreatic diabetes in India. L.G. Creations, Bangalore, pp 147–54

Merdrignac A, Sulpice L, Rayar M, Rohou T, Quéhen E, Zamreek A, Boudjema K, Meunier B (2014) Pancreatic head cancer in patients with chronic pancreatitis. Hepatobiliary Pancreat Dis Int 13(2):192–197

Nouts A, Levy P, Voitot H, Bernades P (1998) Diagnostic value of serum Ca 19-9 antigen in chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterol Clin Biol 22(2):152–9

Perumal S, Palaniappan R, Pillai SA, Velayutham V, Sathyanesan J (2013) Predictors of malignancy in chronic calcific pancreatitis with head mass. World J Gastrointest Surg 5(4):97–103

Bedi MM, Gandhi MD, Jacob G, Lekha V, Venugopal A, Ramesh H (2009) CA 19-9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit? Indian J Gastroenterol 28(1):24–7

Sivarman A, Muthukrishnan A, Senguttvan NB, Suchak SA, Kannan U (2011) Predictors of malignancy in pancreatic head mass: a prospective study. Pan Afr Med J 9:30

Maire F, Micard S, Hammel P, Voitot H, Levy P, Cugnenc PH, Ruszniewski P, Puig PL (2002) Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA. Br J Cancer 87(5):551–4

Liu J, Gao J, Du Y, Li Z, Ren Y, Gu J, Wang X, Gong Y, Wang W, Kong X (2012) Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer 131(3):683–91

Pancreatic Cancer Action / Pancreatic Cancer / News / New blood test can “differentiate between pancreatic cancer and chronic pancreatitis”. http://pancreaticcanceraction.org/news/blood-test-differentiate-pancreatic-cancer-chronic-pancreatitis . Accessed 12th June 2014.

Gold DV, Newsome G, Liu D, Goldenberg DM (2013) Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin. Mol Cancer 12:143

New markers shed light on pancreatic cancer. http://www.mayoclinic.org/medical-professionals/clinical-updates/digestive-diseases/new-markers-shed-light-on-pancreatic-cancer . Accessed 12th June 2014.

Yamada Y, Mori H, Matsumoto S, Kiyosue H, Hori Y, Hongo N (2010) Pancreatic adenocarcinoma versus chronic pancreatitis: differentiation with triple-phase helical CT. Abdom Imaging 35:163–71

Ma X, Zhao X, Ouyang H, Sun F, Zhang H, Zhou C (2013) Quantified ADC histogram analysis: a new method for differentiating mass-forming focal pancreatitis from pancreatic cancer. Acta Radiol. Oct 28

Dawwas MF, Tasha H, Leeds JS, Nayar MK, Oppong KW (2012) Diagnostic accuracy of quantitative EUS elastography for discriminating malignant from benign solid pancreatic masses: a prospective, single-center study. Gastrointest Endosc 76:953–61

Santhosh S, Mittal BR, Bhasin D, Srinivasan R, Rana S, Das A, Nada R, Bhattacharya A, Gupta R, Kapoor R (2013) Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics. J Gastroenterol Hepatol 28:255–61

Rijkers AP, Valkema R, Duivenvoorden HJ, van Eijck CH (2014) Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis. Eur J Surg Oncol 40:794–804

Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R (2010) Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 24(3):349–58